Celiac Artery Compression Syndrome (CACS): A Comprehensive Clinical Guide

1. Comprehensive Introduction & Overview

Celiac Artery Compression Syndrome (CACS), historically and commonly referred to as Median Arcuate Ligament Syndrome (MALS) or Dunbar Syndrome, is a rare and often debated clinical entity characterized by the extrinsic compression of the celiac artery (CA) by the median arcuate ligament (MAL) of the diaphragm.

The median arcuate ligament is a fibrous arch that connects the diaphragmatic crura, forming the anterior border of the aortic hiatus. In patients with CACS, this ligament is positioned abnormally low or is hypertrophied, exerting significant pressure on the celiac artery origin. This compression results in luminal narrowing, which can lead to postprandial abdominal pain, weight loss, and, in some cases, the development of collateral circulation (pancreaticoduodenal arcades).

While anatomical compression of the celiac artery is a relatively common incidental finding on cross-sectional imaging (present in up to 10–25% of the asymptomatic population), the symptomatic clinical syndrome is rare. Because of its non-specific clinical presentation, CACS remains a diagnosis of exclusion, requiring a high index of suspicion and a multidisciplinary approach to differentiate it from other gastrointestinal, vascular, and neurological pathologies.

2. Deep-Dive: Pathophysiology and Mechanism

The pathophysiology of CACS is multifaceted, involving both mechanical vascular obstruction and neurogenic components.

The Mechanical Component

The median arcuate ligament normally crosses the aorta superior to the origin of the celiac artery. In CACS, the ligament crosses anterior to the celiac artery, causing a "hooked" appearance on imaging. This compression leads to:
* Reduced Blood Flow: Significant stenosis of the celiac artery reduces perfusion to the foregut organs (stomach, liver, spleen, pancreas, and proximal duodenum).
* Postprandial Ischemia: During digestion, the metabolic demand of the splanchnic circulation increases. If the celiac artery cannot accommodate this increased flow, the patient experiences "intestinal angina."

The Neurogenic Component

The celiac ganglion, which lies in close proximity to the celiac artery, is often involved in the compression. Chronic irritation or entrapment of the celiac plexus is believed to contribute significantly to the chronic, debilitating pain characteristic of this syndrome. This explains why some patients experience symptom recurrence even after the vascular obstruction is surgically relieved.

Pathophysiological Table: The Triad of CACS

3. Extensive Clinical Indications & Usage

Standard Presentation

The classic patient profile for CACS is a thin individual, typically between the ages of 20 and 50, with a female-to-male ratio of approximately 3:1.

• Abdominal Pain: Usually epigastric, postprandial, and often described as cramping or "gnawing."
• Weight Loss: Often significant, due to "sitophobia" (fear of eating) to avoid pain.
• Bruit: An epigastric systolic bruit is present in approximately 35–80% of patients and may become louder during expiration as the MAL moves inferiorly.
• Nausea/Vomiting: Secondary to foregut hypoperfusion.

Clinical Staging/Grading

While there is no universally accepted "staging" system, clinicians often categorize patients based on the severity of anatomical compression vs. clinical symptoms:

1. Asymptomatic Compression: Incidental finding on CT/Angiography; no treatment required.
2. Symptomatic CACS (Mild): Intermittent postprandial pain, manageable with diet.
3. Symptomatic CACS (Severe): Chronic, debilitating pain, significant weight loss, failure to thrive, documented mesenteric ischemia signs.

4. Differential Diagnosis

Because CACS is a diagnosis of exclusion, the following conditions must be ruled out:

• Gastrointestinal: Gastric ulcers, chronic pancreatitis, cholecystitis, gastroparesis, inflammatory bowel disease (IBD).
• Vascular: Chronic mesenteric ischemia (atherosclerotic), vasculitis (e.g., Takayasu’s).
• Neurological/Functional: Irritable Bowel Syndrome (IBS), functional dyspepsia, abdominal epilepsy.
• Malignancy: Pancreatic cancer or other retroperitoneal tumors causing mass effect.

5. Key Diagnostic Tests

A multimodal diagnostic approach is essential.

Imaging Modalities

• CTA (Computed Tomography Angiography): The gold standard for visualizing the anatomical compression and the "hooked" appearance of the celiac artery.
• MRA (Magnetic Resonance Angiography): Useful for patients with renal insufficiency or those requiring avoidance of radiation.
• Duplex Ultrasound: Excellent for measuring peak systolic velocities (PSV) in the celiac artery. A PSV > 200 cm/s is highly suggestive of significant stenosis.
• Diagnostic Celiac Block: Injection of local anesthetic into the celiac plexus. If the patient experiences temporary relief, it confirms a neurogenic component and predicts a better surgical outcome.

6. Risks, Side Effects, and Contraindications

Surgical Intervention (Celiac Artery Decompression)

The primary treatment is the surgical release of the median arcuate ligament (laparoscopic or open).

• Risks:
  • Vascular Injury: Potential for injury to the aorta or the celiac artery, leading to hemorrhage.
  • Neurogenic Pain: Failure to resolve the neuropathic component of the pain.
  • Recurrence: Fibrotic tissue regrowth can lead to re-stenosis.
• Contraindications:
  • Patients with severe psychiatric comorbidities that may mimic chronic abdominal pain.
  • Patients where the pain is clearly attributable to an alternate, treatable pathology (e.g., peptic ulcer).

7. Long-Term Prognosis

The prognosis following successful surgical decompression is generally favorable for patients who meet all clinical criteria. However, outcomes are highly dependent on patient selection.

• Success Rates: 70–85% of patients report significant symptom relief.
• Factors for Poor Prognosis: Older age, history of smoking, presence of atherosclerotic disease, and long-standing chronic pain (which may cause central sensitization of the nervous system).

8. Massive FAQ Section

1. Is Celiac Artery Compression Syndrome the same as MALS?
Yes, they are synonymous. "Median Arcuate Ligament Syndrome" (MALS) is the most common medical term, while Celiac Artery Compression Syndrome is a more descriptive anatomical diagnosis.

2. Can CACS be diagnosed by imaging alone?
No. Because many healthy individuals have anatomical compression, imaging findings must be correlated with clinical symptoms.

3. Does everyone with celiac artery narrowing need surgery?
Absolutely not. If the narrowing is asymptomatic, surgery is contraindicated.

4. What is "sitophobia"?
Sitophobia is the fear of eating. It is a hallmark of CACS because patients associate food intake with severe, recurring pain.

5. Is the pain in CACS purely ischemic?
Research suggests it is a combination of ischemia (lack of blood flow) and neurogenic pain caused by the compression of the celiac ganglion.

6. What is the role of the celiac plexus block?
It serves as a diagnostic "test-drive." If a patient experiences significant pain relief after the block, it confirms that the celiac plexus is a major contributor to their pain.

7. Is laparoscopic surgery better than open surgery?
Laparoscopic release is now the standard of care, offering shorter recovery times and less postoperative morbidity.

8. What happens if the celiac artery is permanently damaged?
If the artery is severely fibrotic or has an aneurysm, the surgeon may need to perform a bypass graft or angioplasty in addition to the ligament release.

9. Can children get CACS?
Yes, though it is rare. It is more commonly identified in young adults, but pediatric cases have been documented.

10. Why is the pain often worse during expiration?
The diaphragm moves superiorly during expiration, which can tighten the median arcuate ligament and worsen the compression of the celiac artery.

9. Conclusion

Celiac Artery Compression Syndrome represents a complex intersection of vascular anatomy and neurology. While it is a rare diagnosis, its impact on the quality of life for affected patients is profound. Success in clinical management relies on rigorous patient selection, the use of diagnostic celiac blocks to confirm the neurogenic component, and a surgical team experienced in complex retroperitoneal anatomy. Clinicians should maintain a high level of skepticism for "idiopathic" epigastric pain in thin, young patients, ensuring that CACS is considered only after exhaustive exclusion of more common gastrointestinal pathologies.